Dr Reddy ’s buys Wockhardt’s India business for Rs 1850 crore
The business comprises of a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS,Dermatology, Pain and Vaccines, which would transfer to Dr Reddy's along with related sales and marketing teams and the manufacturing plant located in Baddi, Himachal Pradesh with all plant employees.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Brain | Dermatology | India Health | Marketing | Neurology | Pain | Pharmaceuticals | Respiratory Medicine | Skin | Vaccines